{"id":12526,"date":"2026-01-28T10:17:48","date_gmt":"2026-01-28T10:17:48","guid":{"rendered":"https:\/\/csiag.eu\/?p=12526"},"modified":"2026-01-28T12:42:52","modified_gmt":"2026-01-28T12:42:52","slug":"kolloider-er-sikkert-effektive-eller-ej","status":"publish","type":"post","link":"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/","title":{"rendered":"Kolloider - sikkert effektive eller ej?"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_86 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Indholdsfortegnelse<\/p>\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Silber_Ag\" >Kolloidalt s\u00f8lv (Ag)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Aktueller_wissenschaftlicher_Stand\" >Nuv\u00e6rende videnskabelig status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Vorhandene_Studien_und_deren_Limitationen\" >Eksisterende studier og deres begr\u00e6nsninger<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Systematische_Reviews_und_Meta-Analysen\" >Systematiske gennemgange og metaanalyser<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Problematik_der_Bioverfugbarkeit\" >Problemet med biotilg\u00e6ngelighed<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Regulatorische_Position\" >Regulatorisk position<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Dokumentierte_Risiken_bei_oraler_Einnahme\" >Dokumenterede risici ved oral indtagelse<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Gold_Au\" >Kolloidalt guld (Au)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Wissenschaftlicher_Stand\" >Videnskabelig status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Gold_%E2%80%93_Evidenzlage\" >Kolloidt guld - evidensgrundlag<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Bioverfugbarkeit_und_Pharmakokinetik\" >Biotilg\u00e6ngelighed og farmakokinetik<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#24_Sicherheitsprofil\" >2.4 Sikkerhedsprofil<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Kupfer_Cu\" >Kolloidalt kobber (Cu)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Wissenschaftlicher_Stand-2\" >Videnskabelig status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_vs_ionisches_Kupfer\" >Kolloidalt vs. ionisk kobber<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Toxizitatsrisiko\" >Risiko for toksicitet<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Zink_Zn\" >Kolloidalt zink (Zn)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Wissenschaftlicher_Stand-3\" >Videnskabelig status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Evidenz_fur_Zink-Supplementierung_nicht_spezifisch_kolloidal\" >Evidens til fordel for zinktilskud (ikke specifikt kolloid)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Zink_spezifisch\" >Kolloidalt zink specifikt<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Risiken\" >Risici<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Andere_metallische_Kolloide\" >Andre metalliske kolloider<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Platin_Palladium_andere_Edelmetalle\" >Platin, palladium og andre \u00e6delmetaller<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Nicht-metallische_Kolloide\" >Ikke-metalliske kolloider<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Zusammenfassende_Evidenztabelle\" >Tabel med opsummeret dokumentation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Warum_gibt_es_so_wenig_klinische_Forschung\" >Hvorfor er der s\u00e5 lidt klinisk forskning?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Strukturelle_Grunde\" >Strukturelle \u00e5rsager<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Was_bedeutet_das_fur_die_Interpretation\" >Hvad betyder det for fortolkningen?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Praktische_Konzentrationen_in_kommerziellen_Produkten\" >Praktiske koncentrationer i kommercielle produkter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Topische_vs_orale_Anwendung_%E2%80%93_ein_wichtiger_Unterschied\" >Aktuel vs. oral anvendelse - en vigtig forskel<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Belegte_topische_Anwendungen\" >Dokumenterede topiske anvendelser<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Warum_funktioniert_topisch_aber_nicht_oral\" >Hvorfor virker topisk, men ikke oralt?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kritische_Bewertung_von_Anekdoten_und_Erfahrungsberichten\" >Kritisk evaluering af anekdoter og feltrapporter<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Warum_personliche_Berichte_nicht_ausreichen\" >Hvorfor personlige rapporter ikke er nok<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Was_ware_notig_fur_Evidenz\" >Hvad skal der til for at bevise det?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-36\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Wissenschaftliche_Quellen_fur_weitere_Recherche\" >Videnskabelige kilder til yderligere forskning<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-37\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Fazit\" >Konklusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-38\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kernaussagen\" >Vigtige budskaber<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-39\" href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Empfehlungen_aus_wissenschaftlicher_Sicht\" >Anbefalinger fra et videnskabeligt perspektiv<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">L\u00e6setid<\/span> <span class=\"rt-time\"> 6<\/span> <span class=\"rt-label rt-postfix\">minutter<\/span><\/span>\n<p class=\"wp-block-paragraph\">Denne artikel er baseret p\u00e5 offentliggjorte videnskabelige unders\u00f8gelser. Det er vigtigt at forst\u00e5, at frav\u00e6ret af klinisk evidens ikke betyder, at noget er ineffektivt, men blot at der ikke er udf\u00f8rt tilstr\u00e6kkeligt med videnskabeligt kontrollerede unders\u00f8gelser, eller at tidligere unders\u00f8gelser ikke har givet klare resultater.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Alle \u201ehjemme\u201c-generatorer producerer kun <em>ioniseret<\/em> Vand - ikke kolloider! P\u00e5 grund af manglen p\u00e5 laboratoriecertificeret m\u00e5leteknologi, der er tilg\u00e6ngelig for l\u00e6gfolk (de ofte n\u00e6vnte ledningsevnem\u00e5lere giver ikke nogen reproducerbare og derfor p\u00e5lidelige data om <em>ppm<\/em> (dele pr. million) igen), er det altid uvist, hvilken \u201edosis\u201c du tager. De deraf f\u00f8lgende risici er mangfoldige og b\u00f8r ikke undervurderes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Det f\u00f8lgende er videnskabeligt baseret information til bedre orientering.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Silber_Ag\"><\/span>Kolloidalt s\u00f8lv (Ag)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aktueller_wissenschaftlicher_Stand\"><\/span>Nuv\u00e6rende videnskabelig status<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Sammenfatning af beviserne:<\/strong> Til oral indtagelse af kolloidt s\u00f8lv er der <strong>Ingen kliniske unders\u00f8gelser<\/strong>, der viser medicinsk effekt i behandlingen af sygdomme, der opfylder standarderne for evidensbaseret medicin.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Vorhandene_Studien_und_deren_Limitationen\"><\/span>Eksisterende studier og deres begr\u00e6nsninger<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>In vitro-unders\u00f8gelser (laboratorieunders\u00f8gelser):<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Talrige laboratorieunders\u00f8gelser viser antimikrobielle egenskaber:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Morones et al. (2005)<\/strong> i <em>Nanoteknologi<\/em>S\u00f8lvnanopartikler viser antibakteriel effekt mod E. coli i koncentrationer p\u00e5 10-100 \u03bcg\/mL i cellekulturer<\/li>\n\n\n\n<li><strong>Rai et al. (2012)<\/strong> i <em>Anvendt mikrobiologi og bioteknologi<\/em>Antimikrobiel aktivitet mod multiresistente bakterier in vitro<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Vigtig begr\u00e6nsning:<\/strong> In vitro-effekter kan ikke overf\u00f8res direkte til den menneskelige organisme. Ford\u00f8jelseskanalen, pH-v\u00e6rdien, proteinbindingen og andre faktorer \u00e6ndrer biotilg\u00e6ngeligheden dramatisk.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Dyrefors\u00f8g:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hadrup &amp; Lam (2014)<\/strong> i <em>Regulatorisk toksikologi og farmakologi<\/em>Systematisk gennemgang - De fleste dyrefors\u00f8g fokuserer p\u00e5 toksicitet, ikke terapeutisk effekt<\/li>\n\n\n\n<li>Nogle dyrefors\u00f8g viser antimikrobielle effekter, men doseringer og betingelser kan ikke overf\u00f8res til mennesker.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Unders\u00f8gelser p\u00e5 mennesker:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Der er <strong>Ingen offentliggjorte randomiserede, placebokontrollerede dobbeltblindstudier (RCT'er)<\/strong>, som beviser effektiviteten af kolloidalt s\u00f8lv indtaget oralt i behandlingen af infektioner eller andre sygdomme.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Systematische_Reviews_und_Meta-Analysen\"><\/span>Systematiske gennemgange og metaanalyser<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Cochrane Database (2023):<\/strong> Ingen registreringer for oral indtagelse af kolloidt s\u00f8lv mod infektioner<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hadrup et al (2018)<\/strong> i <em>Regulatorisk toksikologi og farmakologi<\/em>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Omfattende gennemgang af s\u00f8lv i medicinske anvendelser<\/li>\n\n\n\n<li>Konklusion: Topisk anvendelse dokumenteret, oral anvendelse utilstr\u00e6kkeligt unders\u00f8gt<\/li>\n\n\n\n<li>Ingen tilstr\u00e6kkelig dokumentation for systemiske terapeutiske effekter<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Problematik_der_Bioverfugbarkeit\"><\/span>Problemet med biotilg\u00e6ngelighed<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hvorfor oral indtagelse er problematisk:<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Proteinbinding:<\/strong> S\u00f8lvioner binder sig til proteiner og kloridioner i ford\u00f8jelseskanalen<\/li>\n\n\n\n<li><strong>Dannelse af AgCl:<\/strong> D\u00e5rligt opl\u00f8seligt s\u00f8lvklorid dannes i maven<\/li>\n\n\n\n<li><strong>Lav absorption:<\/strong> Kun en lille procentdel n\u00e5r blodbanen<\/li>\n\n\n\n<li><strong>Hurtig udryddelse:<\/strong> Om galde og nyrer<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Farmakokinetiske unders\u00f8gelser:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Loeschner et al. (2011)<\/strong> i <em>Partikel- og fibertoksikologi<\/em>: Unders\u00f8gelse af fordelingen af oralt indtagne s\u00f8lvnanopartikler i rotter - lav systemisk biotilg\u00e6ngelighed<\/li>\n\n\n\n<li><strong>Van der Zande et al. (2012)<\/strong> i <em>ACS Nano<\/em>Absorption af s\u00f8lvnanopartikler &lt;1% af den orale dosis<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Regulatorische_Position\"><\/span>Regulatorisk position<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>FDA (USA):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Klassificerer kolloidalt s\u00f8lv som \u201eikke sikkert og effektivt\u201c til medicinsk brug<\/li>\n\n\n\n<li>Forbud mod medicinske krav siden 1999<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>EMA (Europa):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ingen godkendte orale s\u00f8lvpr\u00e6parater til systemiske infektioner<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>BfR (Tyskland):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Advarsel mod ukontrolleret indtagelse<\/li>\n\n\n\n<li>Intet videnskabeligt grundlag for terapeutiske p\u00e5stande<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dokumentierte_Risiken_bei_oraler_Einnahme\"><\/span>Dokumenterede risici ved oral indtagelse<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Argyrie:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Wadhera &amp; Fung (2005)<\/strong> i <em>Amerikansk tidsskrift for klinisk dermatologi<\/em>: Dokumentation af tilf\u00e6lde af argyri efter oral indtagelse af s\u00f8lv<\/li>\n\n\n\n<li>Irreversibel bl\u00e5gr\u00e5 misfarvning af huden<\/li>\n\n\n\n<li>Allerede muligt med kumulative doser p\u00e5 1-5 g s\u00f8lv<\/li>\n\n\n\n<li><strong>Eksempel p\u00e5 beregning:<\/strong> Ved 10 ppm og 50 mL dagligt = 0,5 mg\/dag \u2192 kritisk ophobning mulig efter 5-10 \u00e5r<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Andre dokumenterede bivirkninger:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Neurologiske symptomer (sj\u00e6ldne)<\/li>\n\n\n\n<li>Interaktion med medicin (antibiotika, thyroxin)<\/li>\n\n\n\n<li>Mulig \u00e6ndring i tarmfloraen<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Gulbranson et al. (2000)<\/strong> i <em>Tidsskrift for Toksikologi<\/em>Tilf\u00e6lde af bivirkninger efter langvarig oral indtagelse<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Gold_Au\"><\/span>Kolloidalt guld (Au)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Wissenschaftlicher_Stand\"><\/span>Videnskabelig status<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Medicinsk anerkendte anvendelser:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Guldforbindelser (ikke-kolloidt guld) bruges terapeutisk:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Auranofin og guldnatriumthiomalat:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Godkendt medicin mod reumatoid artrit<\/li>\n\n\n\n<li><strong>Finkelstein et al. (1976)<\/strong> i <em>Annals of Internal Medicine<\/em>: Kliniske unders\u00f8gelser af guldbaserede antireumatiske l\u00e6gemidler<\/li>\n\n\n\n<li><strong>Det er vigtigt:<\/strong> Det er definerede kemiske forbindelser, ikke kolloide suspensioner.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Gold_%E2%80%93_Evidenzlage\"><\/span>Kolloidt guld - evidensgrundlag<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tilg\u00e6ngelig forskning:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Tilf\u00e6ldige observationer:<\/strong> Nogle historiske rapporter fra naturopati<\/li>\n\n\n\n<li><strong>In vitro:<\/strong> Guldnanopartikler viser antiinflammatoriske egenskaber i cellekulturer<\/li>\n\n\n\n<li><strong>Unders\u00f8gelser p\u00e5 mennesker:<\/strong> Ingen publicerede RCT'er om kolloidalt guld, der indtages oralt<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Brown et al. (2010)<\/strong> i <em>Nanomedicin<\/em>Gennemgang af guldnanopartikler i medicin - fokus p\u00e5 l\u00e6gemiddelafgivelse og diagnostik, ikke p\u00e5 direkte terapeutisk effekt ved oral indtagelse<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Bioverfugbarkeit_und_Pharmakokinetik\"><\/span>Biotilg\u00e6ngelighed og farmakokinetik<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Absorption:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Guldnanopartikler absorberes n\u00e6sten ikke i mave-tarmkanalen<\/li>\n\n\n\n<li><strong>Hillyer &amp; Albrecht (2001)<\/strong> i <em>Tidsskrift for farmaceutisk videnskab<\/em>&lt;1% oral biotilg\u00e6ngelighed for nanopartikler<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ingen etableret terapeutisk dosis<\/strong> for kolloidalt guld, n\u00e5r det indtages oralt<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"24_Sicherheitsprofil\"><\/span>2.4 Sikkerhedsprofil<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Generelt kategoriseret som mere sikkert end s\u00f8lv:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ingen risiko for ophobning som med s\u00f8lv (ingen \u201egoldosis\u201c)<\/li>\n\n\n\n<li>Lav toksicitet ved typiske koncentrationer<\/li>\n\n\n\n<li>Men heller ingen dokumenteret effekt, n\u00e5r det tages oralt<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Kupfer_Cu\"><\/span>Kolloidalt kobber (Cu)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Wissenschaftlicher_Stand-2\"><\/span>Videnskabelig status<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Kobber som et vigtigt sporstof:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Kobber er et n\u00f8dvendigt n\u00e6ringsstof (RDA: 0,9 mg\/dag for voksne), men:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Normal kost d\u00e6kker behovet<\/li>\n\n\n\n<li>Tilskud giver kun mening, hvis der er en dokumenteret mangel.<\/li>\n\n\n\n<li><strong>Turnlund et al. (1998)<\/strong> i <em>Amerikansk tidsskrift for klinisk ern\u00e6ring<\/em>: Unders\u00f8gelser af kobber-hom\u00f8ostase<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_vs_ionisches_Kupfer\"><\/span>Kolloidalt vs. ionisk kobber<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Problemet med differentiering:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Mange \u201ekolloide\u201c kobberprodukter indeholder prim\u00e6rt ionisk kobber (Cu\u00b2\u207a).<\/li>\n\n\n\n<li>\u00c6gte kolloide partikler (Cu\u2070) er ustabile og oxiderer hurtigt<\/li>\n\n\n\n<li>Ingen videnskabelig litteratur om den medicinske effekt af specifikt kolloidalt kobber, n\u00e5r det tages oralt<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Toxizitatsrisiko\"><\/span>Risiko for toksicitet<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Kobber har et smalt terapeutisk vindue:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Overdosering:<\/strong> &gt;10 mg\/dag kan f\u00f8re til toksicitet<\/li>\n\n\n\n<li><strong>Wilsons sygdom:<\/strong> Genetisk lidelse med ophobning af kobber - kontraindiceret<\/li>\n\n\n\n<li><strong>Gastrointestinale symptomer:<\/strong> Kvalme, opkastning ved h\u00f8jere doser<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Institut for Medicin (2001)<\/strong>Tolerabelt \u00f8vre indtag = 10 mg\/dag<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Zink_Zn\"><\/span>Kolloidalt zink (Zn)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Wissenschaftlicher_Stand-3\"><\/span>Videnskabelig status<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Zink som et vigtigt sporstof:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Veldokumenteret betydning for immunforsvaret (RDA: 11 mg\/dag for m\u00e6nd, 8 mg\/dag for kvinder)<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Evidenz_fur_Zink-Supplementierung_nicht_spezifisch_kolloidal\"><\/span>Evidens til fordel for zinktilskud (ikke specifikt kolloid)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fork\u00f8lelse:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hemil\u00e4 et al. (2017)<\/strong> i <em>Cochrane-databasen<\/em>: Metaanalyse af zinkpastiller mod fork\u00f8lelse\n<ul class=\"wp-block-list\">\n<li>Resultat: Reduktion af fork\u00f8lelsens varighed med ca. 33%<\/li>\n\n\n\n<li><strong>Det er vigtigt:<\/strong> Studier brugte zinkacetat eller -gluconat, ikke kolloidalt zink<\/li>\n\n\n\n<li>Dosering: 75-100 mg\/dag under almindelig fork\u00f8lelse<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Immunforsvaret:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Prasad (2008)<\/strong> i <em>Tidsskrift for sporstoffer i medicin og biologi<\/em>Zink forbedrer immunforsvaret i tilf\u00e6lde af mangel<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Zink_spezifisch\"><\/span>Kolloidalt zink specifikt<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Mangel p\u00e5 beviser:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ingen publicerede studier, der sammenligner kolloid zinkform med andre former<\/li>\n\n\n\n<li>Ingen beviser for, at kolloid zink har fordele i forhold til konventionelle zinktilskud<\/li>\n\n\n\n<li>Biotilg\u00e6ngelighed sandsynligvis tilsvarende eller d\u00e5rligere end etablerede former (citrat, gluconat)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risiken\"><\/span>Risici<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Overdosering:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Forstyrrelse af kobberabsorptionen ved &gt;50 mg\/dag p\u00e5 lang sigt<\/li>\n\n\n\n<li>Gastrointestinale klager<\/li>\n\n\n\n<li>Tolerabel \u00f8vre gr\u00e6nse: 40 mg\/dag (Institute of Medicine)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Andere_metallische_Kolloide\"><\/span>Andre metalliske kolloider<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Platin_Palladium_andere_Edelmetalle\"><\/span>Platin, palladium og andre \u00e6delmetaller<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Videnskabelig litteratur:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Stort set ingen publicerede humane studier af oral administration<\/li>\n\n\n\n<li>Nogle in vitro-unders\u00f8gelser af platinnanopartiklers antioxidantegenskaber<\/li>\n\n\n\n<li><strong>Ingen etablerede terapeutiske anvendelser<\/strong> n\u00e5r det tages oralt<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Nicht-metallische_Kolloide\"><\/span>Ikke-metalliske kolloider<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Micell\u00e6re vitaminpr\u00e6parater:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dette er en legitim farmaceutisk anvendelse af kolloidteknologi:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Goncalves et al (2021)<\/strong> i <em>N\u00e6ringsstoffer<\/em>Forbedret biotilg\u00e6ngelighed af fedtopl\u00f8selige vitaminer gennem miceller<\/li>\n\n\n\n<li>Klinisk relevant brug ved malabsorption<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Zusammenfassende_Evidenztabelle\"><\/span>Tabel med opsummeret dokumentation<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Kolloid<\/th><th>RCT-evidens<\/th><th>In vitro-aktivitet<\/th><th>Oral biotilg\u00e6ngelighed<\/th><th>Godkendt medicinsk brug oral<\/th><th>Bekymring for sikkerheden<\/th><\/tr><\/thead><tbody><tr><td><strong>s\u00f8lv<\/strong><\/td><td>Ingen<\/td><td>H\u00f8j (antimikrobiel)<\/td><td>Meget lav (&lt;1%)<\/td><td>Ingen<\/td><td>H\u00f8j (argyria)<\/td><\/tr><tr><td><strong>Guld<\/strong><\/td><td>Ingen<\/td><td>Middel (anti-inflammatorisk)<\/td><td>Meget lav (&lt;1%)<\/td><td>Ingen (kolloid form)<\/td><td>Lav<\/td><\/tr><tr><td><strong>Kobber<\/strong><\/td><td>Ingen (som kolloid)<\/td><td>N\/A<\/td><td>Ukendt<\/td><td>Kun i tilf\u00e6lde af en dokumenteret defekt<\/td><td>Mellemh\u00f8j (toksicitet)<\/td><\/tr><tr><td><strong>Zink<\/strong><\/td><td>Ja (andre former)<\/td><td>N\/A<\/td><td>Sandsynligvis lav<\/td><td>Ja (som salt, ikke kolloid)<\/td><td>Afhj\u00e6lpning (i tilf\u00e6lde af overdosering)<\/td><\/tr><tr><td><strong>Platin\/andet<\/strong><\/td><td>Ingen<\/td><td>Svag<\/td><td>Ukendt<\/td><td>Ingen<\/td><td>Ukendt<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Warum_gibt_es_so_wenig_klinische_Forschung\"><\/span>Hvorfor er der s\u00e5 lidt klinisk forskning?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Strukturelle_Grunde\"><\/span>Strukturelle \u00e5rsager<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Manglende patenterbarhed:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Naturlige elementer kan ikke patenteres<\/li>\n\n\n\n<li>Intet \u00f8konomisk incitament til dyre kliniske fors\u00f8g (fase I-III koster 100+ millioner euro)<\/li>\n\n\n\n<li>Medicinalvirksomheder investerer ikke uden eksklusive rettigheder<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Lovgivningsm\u00e6ssige forhindringer:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Uklar klassificering (kosttilskud vs. l\u00e6gemiddel)<\/li>\n\n\n\n<li>Standardiseringsproblemer (varierende partikelst\u00f8rrelser, koncentrationer)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Metodologiske udfordringer:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Vanskelig bl\u00e6nding (farve!)<\/li>\n\n\n\n<li>Kvalitetskontrol af teststoffet<\/li>\n\n\n\n<li>Langsigtede sikkerhedsunders\u00f8gelser p\u00e5kr\u00e6vet<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Was_bedeutet_das_fur_die_Interpretation\"><\/span>Hvad betyder det for fortolkningen?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Frav\u00e6r af beviser \u2260 Bevis for frav\u00e6r<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Frav\u00e6ret af RCT'er betyder ikke n\u00f8dvendigvis, at kolloide metaller er ineffektive. Det betyder det:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Vi har ingen videnskabelig robust bekr\u00e6ftelse af effekten<\/li>\n\n\n\n<li>Vi kan ikke give evidensbaserede doseringsanbefalinger<\/li>\n\n\n\n<li>Langtidssikkerheden er ikke blevet systematisk unders\u00f8gt<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Praktische_Konzentrationen_in_kommerziellen_Produkten\"><\/span>Praktiske koncentrationer i kommercielle produkter<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Typiske koncentrationer p\u00e5 markedet:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Kolloidalt s\u00f8lv:<\/strong> 5-50 ppm (nogle op til 500 ppm)<\/li>\n\n\n\n<li><strong>Kolloidalt guld:<\/strong> 10-30 ppm<\/li>\n\n\n\n<li><strong>Andre metaller:<\/strong> 10-50 ppm<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>S\u00e6dvanlige doseringsoplysninger (producentens anvisninger, ikke evidensbaseret):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>1-3 teskefulde (5-15 ml) dagligt<\/li>\n\n\n\n<li>Ved 10 ppm = 0,05-0,15 mg metal pr. dag<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Videnskabelig evaluering af disse doser:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>For s\u00f8lv og guld: Sandsynligvis for lavt til systemisk effekt med d\u00e5rlig biotilg\u00e6ngelighed<\/li>\n\n\n\n<li>For essentielle sporstoffer (Zn, Cu): Betydeligt under RDA<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Topische_vs_orale_Anwendung_%E2%80%93_ein_wichtiger_Unterschied\"><\/span>Aktuel vs. oral anvendelse - en vigtig forskel<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Belegte_topische_Anwendungen\"><\/span>Dokumenterede topiske anvendelser<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>S\u00f8lv i s\u00e5rbehandling:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Vermeulen et al. (2007)<\/strong> i <em>Cochrane-databasen<\/em>Systematisk gennemgang af s\u00f8lvholdige s\u00e5rforbindinger<\/li>\n\n\n\n<li><strong>Resultat:<\/strong> Moderat evidens for effekt i inficerede s\u00e5r<\/li>\n\n\n\n<li><strong>Mekanisme:<\/strong> Direkte kontakt med bakterier, ingen systemisk absorption n\u00f8dvendig<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>koncentrationer topisk:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Medicinske s\u00e5rforbindinger: 50-100 ppm s\u00f8lv<\/li>\n\n\n\n<li>Direkte antimikrobiel kontakt<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Warum_funktioniert_topisch_aber_nicht_oral\"><\/span>Hvorfor virker topisk, men ikke oralt?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Afg\u00f8rende forskelle:<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Direkte kontakt:<\/strong> S\u00f8lvioner har en direkte lokal effekt p\u00e5 bakterier<\/li>\n\n\n\n<li><strong>Ingen GI-inaktivering:<\/strong> Ingen gastrisk pH, ingen proteinbinding<\/li>\n\n\n\n<li><strong>Lokal koncentration:<\/strong> H\u00f8j koncentration p\u00e5 virkningsstedet mulig<\/li>\n\n\n\n<li><strong>Biotilg\u00e6ngelighed irrelevant:<\/strong> Systemisk absorption ikke n\u00f8dvendig<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kritische_Bewertung_von_Anekdoten_und_Erfahrungsberichten\"><\/span>Kritisk evaluering af anekdoter og feltrapporter<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Warum_personliche_Berichte_nicht_ausreichen\"><\/span>Hvorfor personlige rapporter ikke er nok<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Placebo-effekt:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>For subjektive symptomer (tr\u00e6thed, smerte) er placebo-responsraten ofte 30-40%<\/li>\n\n\n\n<li><strong>Finniss et al. (2010)<\/strong> i <em>Lancet<\/em>: Gennemgang af placeboeffekter<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Spontan remission:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Mange sygdomme (fork\u00f8lelse, milde infektioner) heler spontant<\/li>\n\n\n\n<li>Tidsm\u00e6ssig forbindelse \u2260 Kausalitet<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bekr\u00e6ftelsesbias:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Tendens til at huske og rapportere positive oplevelser<\/li>\n\n\n\n<li>Negative oplevelser dokumenteres mindre hyppigt<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Publikationsforstyrrelser:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Positive resultater er mere tilb\u00f8jelige til at blive offentliggjort end negative.<\/li>\n\n\n\n<li>Mange sm\u00e5 studier med negative resultater forbliver upublicerede<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Was_ware_notig_fur_Evidenz\"><\/span>Hvad skal der til for at bevise det?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Randomiserede, placebokontrollerede, dobbeltblindede unders\u00f8gelser med:<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Tilstr\u00e6kkeligt antal deltagere (power-analyse)<\/li>\n\n\n\n<li>Objektive endepunkter (ikke kun subjektive symptomer)<\/li>\n\n\n\n<li>Standardiseret produkt (defineret partikelst\u00f8rrelse, koncentration)<\/li>\n\n\n\n<li>Peer-reviewed publikation<\/li>\n\n\n\n<li>Replikation af uafh\u00e6ngige forskere<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>S\u00e5danne unders\u00f8gelser findes ikke i \u00f8jeblikket for oral indtagelse af metalliske kolloider.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Wissenschaftliche_Quellen_fur_weitere_Recherche\"><\/span>Videnskabelige kilder til yderligere forskning<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Anbefalede databaser:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>PubMed\/MEDLINE:<\/strong> pubmed.ncbi.nlm.nih.gov\n<ul class=\"wp-block-list\">\n<li>S\u00f8geord: \u201ekolloidalt s\u00f8lv oralt\u201c, \u201eindtagelse af s\u00f8lvnanopartikler\u201c, \u201eoral biotilg\u00e6ngelighed af guldnanopartikler\u201c<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Cochrane-biblioteket:<\/strong> cochranelibrary.com\n<ul class=\"wp-block-list\">\n<li>Systematiske gennemgange og metaanalyser (guldstandard)<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Web of Science:<\/strong> webofscience.com\n<ul class=\"wp-block-list\">\n<li>Citationsanalyse, impact-faktorer<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Vigtige oversigtsartikler:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hadrup &amp; Lam (2014):<\/strong> \u201eOral toksicitet af s\u00f8lvioner, s\u00f8lvnanopartikler og kolloidalt s\u00f8lv - en gennemgang\u201c i <em>Regulatorisk toksikologi og farmakologi<\/em><\/li>\n\n\n\n<li><strong>Fung &amp; Bowen (1996):<\/strong> \u201eS\u00f8lvprodukter til medicinske indikationer: risk-benefit-vurdering\u201c i <em>Tidsskrift for Toksikologi<\/em><\/li>\n\n\n\n<li><strong>Lansdown (2006):<\/strong> \u201eS\u00f8lv i sundhedsv\u00e6senet: antimikrobielle effekter og sikkerhed ved brug\u201c i <em>Biofunktionelle tekstiler og huden<\/em><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Fazit\"><\/span>Konklusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kernaussagen\"><\/span>Vigtige budskaber<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Der findes ingen solide kliniske unders\u00f8gelser af oral indtagelse af metalliske kolloider (is\u00e6r s\u00f8lv og guld).<\/strong>, der ville bevise medicinsk effekt i henhold til standarderne for evidensbaseret medicin.<\/li>\n\n\n\n<li><strong>In vitro-aktivitet (i laboratoriet) er veldokumenteret<\/strong>, is\u00e6r for s\u00f8lv, men <strong>Kan ikke overf\u00f8res til oral indtagelse<\/strong> p\u00e5 grund af ekstremt lav biotilg\u00e6ngelighed.<\/li>\n\n\n\n<li><strong>Lokal p\u00e5f\u00f8ring af s\u00f8lv<\/strong> i s\u00e5rbehandling er <strong>Videnskabeligt bevist<\/strong> - Her fungerer det gennem direkte kontakt.<\/li>\n\n\n\n<li><strong>Risici forbundet med langvarig oral administration er dokumenteret<\/strong>, is\u00e6r argyria i s\u00f8lv.<\/li>\n\n\n\n<li><strong>Manglen p\u00e5 evidens er prim\u00e6rt et forskningsproblem<\/strong>, Det er ikke n\u00f8dvendigvis et bevis p\u00e5 ineffektivitet - der mangler simpelthen unders\u00f8gelser af h\u00f8j kvalitet.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Empfehlungen_aus_wissenschaftlicher_Sicht\"><\/span>Anbefalinger fra et videnskabeligt perspektiv<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hvis du vil tage metalliske kolloider oralt:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Kontakt en l\u00e6ge, is\u00e6r hvis du har eksisterende sygdomme.<\/li>\n\n\n\n<li>V\u00e6r opm\u00e6rksom p\u00e5, at du har en <strong>ikke evidensbaseret<\/strong> V\u00e6lg behandling<\/li>\n\n\n\n<li>Overv\u00e5g mulige bivirkninger<\/li>\n\n\n\n<li>Forvent ikke en \u201emirakeleffekt\u201c<\/li>\n\n\n\n<li>Erstatter ikke evidensbaserede behandlinger<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>For vigtige sporstoffer (zink, kobber):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Konventionelle pr\u00e6parater er bedre unders\u00f8gt og sandsynligvis mere bioaktive<\/li>\n\n\n\n<li>Hvis du har mistanke om en mangel, skal du f\u00f8rst f\u00e5 m\u00e5lt dit blodniveau.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Det videnskabeligt \u00e6rlige svar er:<\/strong> Vi ved det ikke med sikkerhed, fordi de n\u00f8dvendige unders\u00f8gelser aldrig er blevet gennemf\u00f8rt. De tilg\u00e6ngelige data tyder p\u00e5, at den orale biotilg\u00e6ngelighed er for lav til systemiske terapeutiske effekter, men der mangler endelige beviser i form af RCT'er.<\/p>","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">L\u00e6setid<\/span> <span class=\"rt-time\"> 6<\/span> <span class=\"rt-label rt-postfix\">minutter<\/span><\/span>Diese Abhandlung basiert auf ver\u00f6ffentlichten wissenschaftlichen Studien. Es ist entscheidend zu verstehen, dass das Fehlen klinischer Evidenz nicht bedeutet, dass etwas unwirksam ist, sondern lediglich, dass keine ausreichenden wissenschaftlich kontrollierten Studien durchgef\u00fchrt wurden oder bisherige Studien keine eindeutigen Ergebnisse erbracht haben. Alle &#8222;Heim&#8220;-Generatoren erzeugen nur ionisiertes Wasser &#8211; keine Kolloide! Mangels f\u00fcr Laien verf\u00fcgbare laborzertifizierter&hellip;&nbsp;<a href=\"https:\/\/csiag.eu\/da\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/\" rel=\"bookmark\">L\u00e6s mere \"<span class=\"screen-reader-text\">Kolloider - sikkert effektive eller ej?<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-12526","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"modified_by":"Achim Goerner","_links":{"self":[{"href":"https:\/\/csiag.eu\/da\/wp-json\/wp\/v2\/posts\/12526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/csiag.eu\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csiag.eu\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csiag.eu\/da\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/csiag.eu\/da\/wp-json\/wp\/v2\/comments?post=12526"}],"version-history":[{"count":0,"href":"https:\/\/csiag.eu\/da\/wp-json\/wp\/v2\/posts\/12526\/revisions"}],"wp:attachment":[{"href":"https:\/\/csiag.eu\/da\/wp-json\/wp\/v2\/media?parent=12526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csiag.eu\/da\/wp-json\/wp\/v2\/categories?post=12526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csiag.eu\/da\/wp-json\/wp\/v2\/tags?post=12526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}